Accelerating Biologic Therapies
with the power of artificial intelligence

 

Science that evolves how therapies are discovered

EVQLV DEVELOPS ARTIFICIAL INTELLIGENCE ENGINEERED WITH LIFE SCIENCE DATA AND BIOLOGICAL KNOWLEDGE TO ACCELERATE THE SPEED AT WHICH 

BIOLOGICS REACH PATIENTS

Our Technology Offerings

DISCOVER NEXT GENERATION LEADS

Design innovators on existing biologics that possess superior characteristics

ACCELERATE EXISTING LEADS

Using a single biologic candidate, generate superior leads and accelerate to IND-enabling in vivo studies

ANTIBODY COMBINATIONS

Generate combinations of antibodies to offer broader epitope coverage

EXPAND IP PROTECTION

Protect assets by computationally developing a
patentable genus of biologic candidates

HUMANIZE & CROSS REACTIVITY

Receive species-specific biologics through the combination of machine learning and billions of biological data points

MULTI-SITE MUTAGENESIS

Perform evolutionarily informed, multi-site mutagenesis at scale, across the entire biologic sequence

Pin It on Pinterest